Interactions of Apurinic/apyrimidinic endonuclease with a redox inhibitor: Evidence for an alternate conformation of the enzyme

Dian Su, Sarah Delaplane, Meihua Luo, Don L. Rempel, Bich Vu, Mark Kelley, Michael L. Gross, Millie Georgiadis

Research output: Contribution to journalArticle

42 Citations (Scopus)

Abstract

Apurinic/apyrimidinic endonuclease (APE1) is an essential base excision repair protein that also functions as a reduction and oxidation (redox) factor in mammals. Through a thiol-based mechanism, APE1 reduces a number of important transcription factors, including AP-1, p53, NF-κB, and HIF-1α. What is known about the mechanism to date is that the buried residues Cys 65 and Cys 93 are critical for APE1's redox activity. To further detail the redox mechanism, we developed a chemical footprinting-mass spectrometric assay using N-ethylmaleimide (NEM), an irreversible Cys modifier, to characterize the interaction of the redox inhibitor, E3330, with APE1. When APE1 was incubated with E3330, two NEM-modified products were observed, one with two and a second with seven added NEMs; this latter product corresponds to a fully modified APE1. In a similar control reaction without E3330, only the +2NEM product was observed in which the two solvent-accessible Cys residues, C99 and C138, were modified by NEM. Through hydrogen-deuterium amide exchange with analysis by mass spectrometry, we found that the +7NEM-modified species incorporates approximately 40 more deuterium atoms than the native protein, which exchanges nearly identically as the +2NEM product, suggesting that APE1 can be trapped in a partially unfolded state. E3330 was also found to increase the extent of disulfide bond formation involving redox critical Cys residues in APE1 as assessed by liquid chromatography and tandem mass spectrometry, suggesting a basis for its inhibitory effects on APE1's redox activity. Collectively, our results suggest that APE1 adopts a partially unfolded state, which we propose is the redox active form of the enzyme.

Original languageEnglish
Pages (from-to)82-92
Number of pages11
JournalBiochemistry
Volume50
Issue number1
DOIs
StatePublished - Jan 11 2011

Fingerprint

DNA-(Apurinic or Apyrimidinic Site) Lyase
Endonucleases
Corrosion inhibitors
Ethylmaleimide
Conformations
Oxidation
Deuterium
Enzymes
Transcription Factor AP-1
Tandem Mass Spectrometry
Mass spectrometry
Sulfhydryl Compounds
Amides
Liquid Chromatography
DNA Repair
Disulfides
Thermodynamic properties
Mammals
Hydrogen
Mass Spectrometry

ASJC Scopus subject areas

  • Biochemistry

Cite this

Interactions of Apurinic/apyrimidinic endonuclease with a redox inhibitor : Evidence for an alternate conformation of the enzyme. / Su, Dian; Delaplane, Sarah; Luo, Meihua; Rempel, Don L.; Vu, Bich; Kelley, Mark; Gross, Michael L.; Georgiadis, Millie.

In: Biochemistry, Vol. 50, No. 1, 11.01.2011, p. 82-92.

Research output: Contribution to journalArticle

Su, Dian ; Delaplane, Sarah ; Luo, Meihua ; Rempel, Don L. ; Vu, Bich ; Kelley, Mark ; Gross, Michael L. ; Georgiadis, Millie. / Interactions of Apurinic/apyrimidinic endonuclease with a redox inhibitor : Evidence for an alternate conformation of the enzyme. In: Biochemistry. 2011 ; Vol. 50, No. 1. pp. 82-92.
@article{d9170690ab3d4876be9e68614e01b224,
title = "Interactions of Apurinic/apyrimidinic endonuclease with a redox inhibitor: Evidence for an alternate conformation of the enzyme",
abstract = "Apurinic/apyrimidinic endonuclease (APE1) is an essential base excision repair protein that also functions as a reduction and oxidation (redox) factor in mammals. Through a thiol-based mechanism, APE1 reduces a number of important transcription factors, including AP-1, p53, NF-κB, and HIF-1α. What is known about the mechanism to date is that the buried residues Cys 65 and Cys 93 are critical for APE1's redox activity. To further detail the redox mechanism, we developed a chemical footprinting-mass spectrometric assay using N-ethylmaleimide (NEM), an irreversible Cys modifier, to characterize the interaction of the redox inhibitor, E3330, with APE1. When APE1 was incubated with E3330, two NEM-modified products were observed, one with two and a second with seven added NEMs; this latter product corresponds to a fully modified APE1. In a similar control reaction without E3330, only the +2NEM product was observed in which the two solvent-accessible Cys residues, C99 and C138, were modified by NEM. Through hydrogen-deuterium amide exchange with analysis by mass spectrometry, we found that the +7NEM-modified species incorporates approximately 40 more deuterium atoms than the native protein, which exchanges nearly identically as the +2NEM product, suggesting that APE1 can be trapped in a partially unfolded state. E3330 was also found to increase the extent of disulfide bond formation involving redox critical Cys residues in APE1 as assessed by liquid chromatography and tandem mass spectrometry, suggesting a basis for its inhibitory effects on APE1's redox activity. Collectively, our results suggest that APE1 adopts a partially unfolded state, which we propose is the redox active form of the enzyme.",
author = "Dian Su and Sarah Delaplane and Meihua Luo and Rempel, {Don L.} and Bich Vu and Mark Kelley and Gross, {Michael L.} and Millie Georgiadis",
year = "2011",
month = "1",
day = "11",
doi = "10.1021/bi101248s",
language = "English",
volume = "50",
pages = "82--92",
journal = "Biochemistry",
issn = "0006-2960",
publisher = "American Chemical Society",
number = "1",

}

TY - JOUR

T1 - Interactions of Apurinic/apyrimidinic endonuclease with a redox inhibitor

T2 - Evidence for an alternate conformation of the enzyme

AU - Su, Dian

AU - Delaplane, Sarah

AU - Luo, Meihua

AU - Rempel, Don L.

AU - Vu, Bich

AU - Kelley, Mark

AU - Gross, Michael L.

AU - Georgiadis, Millie

PY - 2011/1/11

Y1 - 2011/1/11

N2 - Apurinic/apyrimidinic endonuclease (APE1) is an essential base excision repair protein that also functions as a reduction and oxidation (redox) factor in mammals. Through a thiol-based mechanism, APE1 reduces a number of important transcription factors, including AP-1, p53, NF-κB, and HIF-1α. What is known about the mechanism to date is that the buried residues Cys 65 and Cys 93 are critical for APE1's redox activity. To further detail the redox mechanism, we developed a chemical footprinting-mass spectrometric assay using N-ethylmaleimide (NEM), an irreversible Cys modifier, to characterize the interaction of the redox inhibitor, E3330, with APE1. When APE1 was incubated with E3330, two NEM-modified products were observed, one with two and a second with seven added NEMs; this latter product corresponds to a fully modified APE1. In a similar control reaction without E3330, only the +2NEM product was observed in which the two solvent-accessible Cys residues, C99 and C138, were modified by NEM. Through hydrogen-deuterium amide exchange with analysis by mass spectrometry, we found that the +7NEM-modified species incorporates approximately 40 more deuterium atoms than the native protein, which exchanges nearly identically as the +2NEM product, suggesting that APE1 can be trapped in a partially unfolded state. E3330 was also found to increase the extent of disulfide bond formation involving redox critical Cys residues in APE1 as assessed by liquid chromatography and tandem mass spectrometry, suggesting a basis for its inhibitory effects on APE1's redox activity. Collectively, our results suggest that APE1 adopts a partially unfolded state, which we propose is the redox active form of the enzyme.

AB - Apurinic/apyrimidinic endonuclease (APE1) is an essential base excision repair protein that also functions as a reduction and oxidation (redox) factor in mammals. Through a thiol-based mechanism, APE1 reduces a number of important transcription factors, including AP-1, p53, NF-κB, and HIF-1α. What is known about the mechanism to date is that the buried residues Cys 65 and Cys 93 are critical for APE1's redox activity. To further detail the redox mechanism, we developed a chemical footprinting-mass spectrometric assay using N-ethylmaleimide (NEM), an irreversible Cys modifier, to characterize the interaction of the redox inhibitor, E3330, with APE1. When APE1 was incubated with E3330, two NEM-modified products were observed, one with two and a second with seven added NEMs; this latter product corresponds to a fully modified APE1. In a similar control reaction without E3330, only the +2NEM product was observed in which the two solvent-accessible Cys residues, C99 and C138, were modified by NEM. Through hydrogen-deuterium amide exchange with analysis by mass spectrometry, we found that the +7NEM-modified species incorporates approximately 40 more deuterium atoms than the native protein, which exchanges nearly identically as the +2NEM product, suggesting that APE1 can be trapped in a partially unfolded state. E3330 was also found to increase the extent of disulfide bond formation involving redox critical Cys residues in APE1 as assessed by liquid chromatography and tandem mass spectrometry, suggesting a basis for its inhibitory effects on APE1's redox activity. Collectively, our results suggest that APE1 adopts a partially unfolded state, which we propose is the redox active form of the enzyme.

UR - http://www.scopus.com/inward/record.url?scp=78650907161&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78650907161&partnerID=8YFLogxK

U2 - 10.1021/bi101248s

DO - 10.1021/bi101248s

M3 - Article

C2 - 21117647

AN - SCOPUS:78650907161

VL - 50

SP - 82

EP - 92

JO - Biochemistry

JF - Biochemistry

SN - 0006-2960

IS - 1

ER -